Sfondo Header
L'angolo del dottorino
Contents
Search the site... Advanced search
✖

Congenital septal defects and shunts

Congenital septal defects and shunts encompass abnormalities that allow blood to cross a communication between normally separate compartments or to flow through a vascular connection that should cease to be functionally relevant after birth. The term septal defect describes an anatomical feature, whereas the term shunt refers to the passage of blood from one circuit into another. These concepts overlap only in part: a patent ductus arteriosus causes a shunt without being a defect of the cardiac septum, whereas a small communication may have negligible hemodynamic consequences. Understanding the condition therefore requires assessment of the location, direction and volume of flow, together with the response of the cardiac chambers and pulmonary vasculature.

These abnormalities account for an important proportion of congenital heart disease, but their apparent prevalence changes with inclusion criteria and age at diagnosis. Small ventricular septal defects are identified much more frequently when systematic echocardiography is performed; some atrial communications, by contrast, remain minimally symptomatic until adulthood. Overall estimates for cardiac malformations cannot be treated as though they described a single homogeneous category. Detection of communications that will decrease in size or close spontaneously also changes the proportions observed in pediatric registries compared with adult series.

Clinical significance does not follow a simple ranking based on diameter. A large communication at ventricular level can cause pulmonary overcirculation during the first months of life, whereas a substantial atrial communication may cause slowly progressive volume overload. A small lesion near a valve or the conduction system may require attention for reasons unrelated to shunt volume. The distinction between observation, elective treatment and timely intervention arises from integrating these factors, not simply from the presence of an anatomical passage.

Origin and organization of the communications

Cardiac septation results from interactions among myocardial growth, mesenchymal tissues, valve development and alignment of the connections. It does not consist of building a uniform wall that simply divides the heart into two halves. Atrial, ventricular and atrioventricular components develop in relation to blood flow and adjacent structures; a defect may therefore coexist with valvular, venous or outflow tract abnormalities. This shared developmental origin explains why identifying a communication must always be followed by assessment of the other parts of the heart, even when the initial finding appears isolated.

Atrial communications include anatomically different configurations. In an ostium secundum atrial septal defect the defect involves the fossa ovalis region; in an ostium primum defect the inferior communication is part of a common atrioventricular junction. Sinus venosus defects involve the relationships among the venae cavae, atria and pulmonary venous return, whereas a coronary sinus defect involves the partition between the coronary sinus and the left atrium. Grouping them under the term atrial septal defect is clinically useful, provided their distinct morphological identities are preserved.

The patent foramen ovale requires a further distinction. In the fetus this communication is physiological and allows blood to reach the left side of the heart; after birth, increased left atrial pressure promotes apposition of the flap. If anatomical fusion does not occur, a potential passage may persist without a true tissue deficiency equivalent to that of an ostium secundum defect. As a rule, an isolated finding does not produce the right-sided volume overload typical of a significant atrial shunt. Conditions allowing right-to-left passage and any embolic implications must be considered separately, without automatically applying indications for septal defect closure.

The ventricular septal defect is described in terms of its margins and position relative to right ventricular components. A perimembranous communication has different relationships from a defect surrounded by muscle; an inlet or outlet location adds information without replacing a description of the borders. Muscular defects may have multiple openings. Inlet and outlet variants require careful attention to the valves, alignment and course of conduction tissue, because these relationships influence complications and repair options.

In atrioventricular septal defect the defining feature is the common atrioventricular junction. This is not the coincidental combination of an atrial hole, a ventricular hole and an abnormal valve. The configuration of the leaflets and their attachments determines the level or levels at which blood can communicate. Partial and complete forms have different consequences; regurgitation of the left atrioventricular valve component may add a substantial burden even when shunting is not the only major problem. Accurate description of this anatomy is essential for interpreting echocardiography and planning reconstruction.

Extracardiac shunts primarily include the patent ductus arteriosus and the aortopulmonary window. The former represents persistence of a connection essential to fetal circulation; the latter is a communication between the great vessels despite separate arterial roots and valves. Their shared ability to divert blood from the aorta into the pulmonary artery does not make these diagnoses interchangeable. Location, extent and associated lesions affect pulmonary pressure exposure, urgency and treatment technique. Ductal patency in a preterm infant must also be distinguished from a persistent ductus in a term-born child, because maturation and respiratory conditions change the biological context.

The etiology is heterogeneous. Genetic variants, chromosomal abnormalities and developmental disturbances may contribute through different mechanisms; the association with trisomy 21 is particularly important in atrioventricular septal defects, whereas some familial forms of atrial septal defect are associated with conduction disturbances. Reproductive history, affected relatives and extracardiac findings guide evaluation. An isolated septal defect does not automatically imply a syndrome, and a negative molecular diagnosis does not exclude all genetic contributions. Counseling must distinguish an identified cause from the empirical recurrence risk and associations observed in populations.

Shunt anatomy and hemodynamic consequences

A left-to-right shunt returns a proportion of blood that has already traversed the pulmonary circulation to the lungs. Systemic arterial oxygen saturation may remain normal, but the cost is increased flow and workload in the involved chambers. In right-to-left shunting, some venous blood instead enters the arterial circulation without normal pulmonary oxygenation. Direction is not an immutable property of the opening: it depends on pressures, resistance, compliance and phase of the cardiac cycle. Predominantly left-to-right flow may include brief reverse components without this amounting to established cyanotic physiology.

The distinction between pretricuspid and posttricuspid communications helps explain their different hemodynamic loads. At atrial level, flow encounters the ventricles during filling and is affected by their diastolic properties; overload mainly affects the right heart and pulmonary circulation. At ventricular or arterial level, the pulmonary vascular bed may also be exposed to high pressures, depending on the size of the communication and any associated obstructions. This explains why the risk and timing of pulmonary vascular disease are not identical across defects. It is not, however, a sufficient classification when multiple lesions or anomalous venous return coexist.

In an atrial septal defect, the right ventricle’s greater ability to accept blood at low pressure usually promotes passage from the left to the right atrium. Right-sided dilation therefore becomes a marker of chronic loading, even when the interatrial pressure gradient is small. With aging, a less compliant left ventricle may increase shunting; conversely, elevated right-sided pressure may reduce it or change its direction. This dynamic explains both late symptom onset and the risk that closure, in the presence of left heart disease, may abruptly increase pressure upstream of the left ventricle.

In ventricular septal defects, restrictiveness describes the communication’s ability to maintain a pressure gradient between the ventricles. A small opening can generate high velocities with limited blood flow; a large opening permits greater pressure transmission, and flow depends mainly on the balance between pulmonary and systemic vascular resistance. Additional blood reaching the lungs then returns to the left atrium and ventricle, explaining left heart dilation in significant ventricular shunts. Murmur intensity does not directly measure this volume: a small restrictive defect can be very loud, whereas a large defect with nearly equalized pressures may be quieter.

The Qp/Qs ratio, between pulmonary and systemic blood flow, quantifies the overall flow imbalance. A value of 2 means that measured pulmonary flow is twice systemic flow, not that half of the heart is necessarily inefficient or that closure is automatically indicated. The ratio must be consistent with chamber dimensions, flow direction and measurement method. In circuits with multiple communications or collateral vessels, an isolated measurement may be misleading. A decrease in this ratio over time also needs interpretation: it may reflect favorable spontaneous closure or an increase in pulmonary vascular resistance that restricts shunting.

The neonatal transition profoundly changes clinical presentation. Immediately after birth, pulmonary vascular resistance is still relatively high and may limit flow through a large communication; its progressive decline makes pulmonary overcirculation apparent over the following weeks. Thus, an initially stable infant may develop tachypnea and feeding difficulties without any increase in defect size. In complex congenital heart disease, however, a communication may be necessary for mixing or maintaining cardiac output. Before viewing a shunt solely as pathological, the entire circuit must be understood, because closing an essential passage can compromise survival.

Pulmonary arterial pressure is not synonymous with pulmonary vascular resistance. High flow may raise pressure without irreversible vascular disease, whereas a remodeled vascular bed may have high resistance even after shunt volume has decreased. Assessment also distinguishes a precapillary component from one caused by elevated left heart pressures. Eisenmenger syndrome denotes progression of a systemic-to-pulmonary shunt to advanced pulmonary vascular disease with bidirectional or right-to-left flow and desaturation. At this stage, eliminating the communication does not remove pulmonary vascular obstruction and may deprive the right ventricle of a decompression pathway.

Clinical manifestations at different ages

The clinical history should establish when symptoms appear and which activities reveal them. In infants, feeding represents prolonged exertion: frequent pauses, sweating, rapid breathing and poor growth may indicate substantial hemodynamic load. Respiratory infection frequency alone is nonspecific and must be considered alongside the infant’s condition between episodes, nutritional requirements and growth curve. An isolated atrial defect is often better tolerated than a large posttricuspid shunt; very early or severe symptoms should therefore prompt investigation for associated conditions, prematurity, venous anomalies, valve regurgitation or lung disease.

In older children, reduced exercise tolerance may be evident by comparison with peers, but may sometimes be concealed because the child spontaneously adapts activity levels. Assessment includes shortness of breath, the need to stop, performance of usual activities and growth trends. A murmur detected incidentally does not prove severe heart disease; likewise, a seemingly normal life does not rule out chronic overload. Clinical history becomes meaningful when compared with cardiac chamber responses and documented changes over time.

In adults, dyspnea, fatigue and palpitations may be the first manifestation of an unrecognized defect. Increased shunting owing to reduced left ventricular compliance, the development of arrhythmias or the onset of pulmonary hypertension can interrupt a long period of compensation. A history of stroke or embolism requires differentiation among atrial fibrillation, paradoxical embolism and independent vascular causes. Syncope, especially during exertion or with signs of pulmonary hypertension, requires specific evaluation: it must not automatically be attributed to the mere presence of a communication. Records of previous interventions also help distinguish native defects, residual lesions and consequences of repair.

The physical examination begins by observing breathing, growth and perfusion. Tachypnea, retractions, feeding difficulties and hepatomegaly may accompany infant heart failure; in adults, venous pressure, edema and signs of congestion become important. Oxygen saturation and blood pressure should be measured with appropriate instruments and under suitable conditions. Normal saturation is compatible with a significant left-to-right shunt, whereas desaturation calls for assessment of whether flow has reversed, an associated anomaly is present or respiratory disease contributes. In ductal communications with reverse flow, the distribution of desaturation may differ between upper and lower limbs.

Auscultation reflects lesion-related blood flow rather than simply the anatomical opening. In atrial septal defects, a pulmonary systolic ejection murmur often results from increased flow across the pulmonary valve, while widely split and relatively fixed splitting of the second heart sound may suggest right-sided volume overload. A restrictive ventricular defect may produce a holosystolic murmur; under appropriate hemodynamic conditions, a patent ductus may produce a continuous murmur. Findings change with age, pulmonary pressure and effective shunt size. An accentuated second heart sound or disappearance of a previously audible murmur may have adverse significance if accompanied by rising pulmonary pressure.

The presence of valve regurgitation can change the entire examination picture. In defects of the atrioventricular junction, a murmur generically attributed to shunting may also include a component from the left atrioventricular valve; in some ventricular defects, proximity to the aortic valve may promote cusp prolapse and regurgitation. Clinical assessment must therefore link each finding to a mechanism and verify agreement with imaging. Peripheral signs, pulse characteristics and murmur location help formulate hypotheses, but no combination of auscultatory findings replaces anatomical definition of the defect.

Investigations and diagnostic assessment

Transthoracic echocardiography is generally the first investigation able to confirm the lesion and describe its impact. Assessment includes septa, atrioventricular junctions, valves, arterial connections and venous return; it should not stop after identifying the first abnormal jet. Dimensions are measured in multiple views and interpreted according to age and body surface area. In children, acoustic windows often allow detailed definition; in adults, some structures may require complementary techniques. The initial goal is to establish a coherent description of the circulation on which subsequent investigations can be based.

Doppler identifies the direction, duration and velocity of flows, but each measurement has technical assumptions. A high-velocity jet across a ventricular defect suggests a substantial pressure gradient between chambers, without automatically indicating a large shunt. Right ventricular systolic pressure estimated from tricuspid regurgitation is not the same as pulmonary arterial pressure if right ventricular outflow obstruction is present. Color Doppler may exaggerate or reduce the apparent extent of a jet depending on the settings. Anatomical confirmation prevents signal dropout artifacts from being mistaken for true defects and allows multiple communications to be identified.

Chamber dimensions provide an independent check on hemodynamic significance. Disproportionate right heart dilation calls for investigation of an atrial shunt or anomalous venous return, even when the fossa ovalis appears intact; left-sided dilation may accompany recirculation from a ventricular or ductal communication. Assessment includes systolic function, interventricular septal motion, regurgitation and indirect signs of elevated pressure. None of these findings should be interpreted in isolation. Disagreement between an apparently small defect and marked chamber dilation is a diagnostic problem to resolve, not a detail to overlook.

The electrocardiogram contributes information about overload, electrical axis, conduction and arrhythmias, but a normal tracing does not rule out a communication. Ambulatory monitoring is selected according to symptoms and the likelihood of documenting an intermittent event. Chest radiography may reveal cardiomegaly or changes in pulmonary vascular markings when clinically useful, without being a mandatory step for every patient. Blood tests, iron assessment and renal function testing are guided by the clinical context; they are particularly important with cyanosis, congestion, diuretic treatment or suspected systemic complications.

Transesophageal echocardiography offers better definition of selected defect rims, venous relationships and posterior structures, and can guide selected interventions. Three-dimensional reconstruction helps describe opening shape and relationships to valves and adjacent tissues, but complements two-dimensional assessment rather than removing the need for correct anatomical identification. When more reproducible measurement of ventricular volumes and flows is needed, cardiac magnetic resonance imaging can quantify Qp/Qs and clarify venous return. Computed tomography is reserved for questions where anatomical resolution or patient characteristics provide an advantage, taking radiation exposure and contrast material into account.

Cardiac catheterization is used when invasive measurements may change treatment decisions, particularly in suspected pulmonary vascular disease or discrepant findings. Pressures and saturations obtained at appropriate sites allow shunting to be characterized and resistance calculated; estimated oxygen consumption, ventilation conditions and sampling quality can affect the result. Selective tests or temporary occlusions address specific questions and do not replace comprehensive clinical judgment. Operability requires integration of measurements with anatomy, age, desaturation, chamber function and defect type, avoiding a single threshold applied to all communications.

Prenatal diagnosis has particular limitations: some passages are physiological in the fetus, and small defects may not be identifiable with certainty. Fetal echocardiography also assesses valves, connections and associated anomalies, allowing postnatal investigations to be planned when needed. After birth, suspected syndromic disease or a family history guides genetic evaluation with appropriate counseling. The differential diagnosis of dilation, murmur or dyspnea includes anomalous venous return, valve disease, pulmonary disease and cardiomyopathies; identifying a communication does not rule out another condition contributing to symptoms.

Treatment principles and prognosis

The choice between monitoring and closure depends on the expected harm if the defect remains open and the benefit reasonably achievable through correction. A small communication with no overload or complications may require only proportionate follow-up; substantial recirculation, impaired growth or a progressive valve lesion may justify intervention even before the patient reports significant symptoms. Spontaneous reduction in size is possible only for certain anatomies and must not be assumed for defects that do not follow this course. Observation is an active clinical decision, with defined goals and criteria for reassessment.

The timing of repair differs among lesions. Large posttricuspid shunts may require early treatment to protect growth and the pulmonary vasculature; some atrial defects allow later elective repair when stable. The timetable for one condition must not be applied to all others. Atrioventricular regurgitation, aortic cusp prolapse, pulmonary pressures and syndromic conditions may alter priorities. Decisions should also account for weight, anatomy and the likelihood of durable repair, without using anticipated growth as a reason to prolong clinically important overload.

Percutaneous closure is possible for many ostium secundum defects with suitable rims, many patent ducts and selected ventricular defects. However, availability of a device does not mean every communication can be treated: tissue support, distance from valves, access routes and relationships to the conduction system are crucial. Complex anatomies may require specialized techniques that are not equivalent to simply deploying an occluder used for the fossa ovalis. Clinical indication is established before selecting a device; assessment must include the consequences of potential failure and options for surgical rescue.

Surgery remains essential when valve reconstruction, correction of venous return or closure of communications with unfavorable relationships is required. In atrioventricular septal defects, separating blood flows and achieving a competent valve are closely linked goals. In ventricular septal defects, suturing must respect valves and the conduction system; in arterial shunts, distortion or narrowing of adjacent vessels must be avoided. Outcomes should be judged by residual shunting, valve competence, gradients and function, as well as the technical success of closure. The surgical approach is selected without allowing scar appearance alone to take precedence over repair quality.

Medical treatment supports patients with congestion, arrhythmias or other consequences, but generally does not eliminate a structural defect. In an infant with pulmonary overcirculation, nutritional support and treatment of congestion may facilitate stabilization; ongoing need for such measures informs the judgment about timely intervention. Pharmacological ductal closure under certain conditions in preterm infants belongs to a specific context and cannot be generalized to persistent ductus in older children. In duct-dependent circulations, conversely, the goal may be to maintain patency: the same anatomical structure has opposite significance depending on the associated cardiac defect.

The presence of pulmonary arterial hypertension fundamentally changes the decision-making process. Updated recommendations distinguish favorable situations, those requiring specialist assessment and conditions in which closure is contraindicated. Strategies combining pulmonary vascular disease treatment with subsequent repair concern selected patients and do not establish that every pulmonary vascular bed can be made operable. In atrial defects, moreover, a poorly compliant left ventricle may not tolerate elimination of a decompression route. With Eisenmenger physiology, treatment aims to address risk and functional capacity without assuming that closing the opening is the ultimate solution.

Prognosis can be very favorable when treatment precedes substantial injury and no important sequelae remain. Late repair may still offer benefit but does not necessarily reverse atrial fibrosis, arrhythmias, vascular disease or valve disease. Post-intervention assessment must document regression of overload and identify residual problems, tailoring follow-up intervals to the lesion and clinical history. Transition to adult care preserves knowledge of the anatomy and procedures performed, avoiding the assumption that successful repair is a universal reason to discontinue surveillance.

Physical activity, work and pregnancy are assessed according to current physiology. A small or correctly repaired defect may be compatible with a fully active life, whereas desaturation, arrhythmias, dysfunction or high pulmonary pressure require specific recommendations. Preconception counseling also considers medications, recurrence risk and interventions that may be needed before pregnancy. The mere presence of a communication does not justify a blanket prohibition or make risk irrelevant in advanced disease. A proportionate care plan preserves permitted activities and identifies conditions in which additional physiological load may be dangerous.

Complications and long-term surveillance

Cardiac chamber remodeling may become progressively less reversible if overload persists. Atrial and ventricular dilation, changes in valve geometry and altered filling pressures may promote heart failure and reduced exercise capacity. In atrial defects, the right heart is particularly important; with large ventricular or ductal shunts, volume loading often clearly involves the left chambers as well. Surveillance therefore looks for changes from the previous condition, not simply whether a single threshold has been crossed. Apparently stable symptoms do not rule out an unfavorable anatomical course.

Atrial arrhythmias may develop after years of dilation or following repair, when scarring and remodeling provide a favorable substrate. Shunt closure reduces loading but does not always eliminate this substrate, particularly with late diagnoses. Conduction disturbances may result from a genetic predisposition, the anatomical relationships of the defect or treatment. A new arrhythmia requires assessment of both the electrical problem and hemodynamic status, because it may be the first manifestation of deteriorating valve or ventricular function. Treatment is tailored to the malformation and previous procedures.

Advanced pulmonary vascular disease has consequences beyond the heart. In chronic cyanosis, increased red cell mass contributes to oxygen transport, but iron deficiency, hemostatic abnormalities, thrombotic risk and bleeding may coexist. High hemoglobin alone does not automatically justify phlebotomy and does not fully describe oxygen transport adequacy. Hemoptysis, syncope, worsening saturation and signs of low cardiac output require prompt assessment. At this disease stage, specialist care is particularly important for interpreting findings within cyanotic physiology.

Valvular complications may alter prognosis even without a large residual shunt. Aortic cusp prolapse in some ventricular defects, left atrioventricular valve regurgitation in common-junction defects and geometric changes due to dilation require specific assessment. After repair, new stenosis or regurgitation must not be confused with persistence of the original defect. Checking only the integrity of a patch or device would be insufficient: surveillance must include all structures sharing the communication’s margins or involved in reconstruction.

Infective endocarditis has different probabilities depending on the underlying substrate and the presence of prosthetic material or residual lesions. Prevention includes oral health and infection management; antibiotic prophylaxis for selected procedures is restricted to guideline-defined conditions, not every murmur or communication. Thromboembolic complications also require mechanism-specific analysis: atrial fibrillation, device-related thrombosis and paradoxical embolism are distinct mechanisms. Identification of a defect does not automatically prove that it caused a neurological event, nor does it alone establish the need for anticoagulation or closure.

Procedural complications include vascular injury, residual shunting, valve interference, conduction abnormalities and, with some devices, dislodgement or injury to adjacent structures. Risk profiles depend on technique and anatomy and must be compared with the risk of leaving the defect untreated. Clinical assessment after treatment distinguishes expected findings from new warning signs such as dyspnea, chest pain, persistent palpitations or fever. A favorable outcome also requires clear documentation of the defect, implanted material and residual problems, so that future decisions can reflect the circulation actually achieved.

References
  1. Liu Y et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. International Journal of Epidemiology. 2019;48(2):455-463.
  2. Geva T et al. Atrial septal defects. The Lancet. 2014;383(9932):1921-1932.
  3. Spicer DE et al. Ventricular septal defect. Orphanet Journal of Rare Diseases. 2014;9:144.
  4. Baumgartner H et al. 2020 ESC Guidelines for the management of adult congenital heart disease. European Heart Journal. 2021;42(6):563-645.
  5. Gurvitz M et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2026;87(7):822-976.
  6. Anderson RH et al. Development of the heart: (2) Septation of the atriums and ventricles. Heart. 2003;89(8):949-958.
  7. Pierpont ME et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. Circulation. 2018;138(21):e653-e711.
  8. Silvestry FE et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. Journal of the American Society of Echocardiography. 2015;28(8):910-958.
  9. Schneider DJ et al. Patent ductus arteriosus. Circulation. 2006;114(17):1873-1882.
  10. Humbert M et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2022;43(38):3618-3731.
  11. Fratz S et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. Journal of Cardiovascular Magnetic Resonance. 2013;15(1):51.
  12. Khalil M et al. Acute therapy of newborns with critical congenital heart disease. Translational Pediatrics. 2019;8(2):114-126.
  13. Hernández-Madrid A et al. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital Heart Disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018;20(11):1719-1753.
  14. Moon-Grady AJ et al. Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2023;36(7):679-723.
  15. De Backer J et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. European Heart Journal. 2025;46(43):4462-4568.
  16. Delgado V et al. 2023 ESC Guidelines for the management of endocarditis. European Heart Journal. 2023;44(39):3948-4042.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.